China's first COVID-19 pill included in medical reimbursement list

Download

China's first COVID-19 pill, Azvudine, approved by the country's health regulator in late July, has been included in the medical reimbursement list temporarily, according to a new COVID-19 treatment guideline.

The medical reimbursement list is a catalog of drugs covered under China's social security system.

Open in CGTN APP for better experience

Search Trends